H.R. 2726 (111th): Counterfeit Drug Enforcement Act of 2009

Introduced:

Jun 4, 2009
111th Congress, 2009–2010

Status:
Died in a previous Congress

This bill was introduced on June 4, 2009, in a previous session of Congress, but was not enacted.

Sponsor:

Steve Israel
Representative for New York's 2nd congressional district
Democrat

Text:

Read Text »
Last Updated: Jun 4, 2009
Length: 10 pages

About the bill

Full Title

To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes.

Read CRS Summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 4076 (110th) was a previous version of this bill.

Referred to Committee
Last Action: Nov 5, 2007

H.R. 6679 (112th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: Dec 18, 2012

What is a bill?

The “H.R.” in “H.R. 2726” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jun 4, 2009

Details

Cosponsors
1 cosponsors (1D) (show)
Committee Assignments
Health

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: